XERS - Xeris Biopharma Holdings, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
8.2 1.05 (12.8%)	0.0 (0.0%)	0.0 (0.0%)	-0.02 (-0.22%)	0.04 (0.49%)	1.12 (13.76%)	0.15 (1.65%)	0.15 (1.65%)

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.01
Diluted EPS:: -0.01
Basic P/E:: -925.0
Diluted P/E:: -925.0
RSI(14) 1m:: 100.0
VWAP:: 9.25
RVol:: 2.502

Events

Period	Kind	Movement	Occurred At
Day	Rvol 2 increase day	rvol 2.0, 9.19 +0.99 (+12.01%)	Oct 15 15:18
Day	Price increase day	9.04 +0.84 (+10.24%)	Oct 15 14:26
1m	Price increase 1m	8.76 +0.15 (+1.68%)	Oct 15 11:47
60m	Price increase 60m	8.54 +0.41 (+5.03%)	Oct 15 09:57